The 2020 ISPE Asia Pacific Pharma Manufacturing Virtual Conference & Executive Forum has been reimagined into a virtual experience that will immerse attendees in actionable, interactive discussions around strategies to make their manufacturing operations more agile, compliant, and resilient to disruption. Education sessions feature case studies and dedicated Q&A time with experts representing FDA, Medicines and Healthcare products Regulatory Agency (MHRA), local health authorities, Pfizer, Biocon, and more.
Get a taste of what you can expect as Conference Co-Chair Carmelo Rosa, PsyD, Director, Division of Drug Quality I, FDA/CDER/OC/OMQ, answers the question: Why are regulatory inspectors still finding problems in Out-of-Specifications (OOS) Investigations?
